Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

Head Lice Infestation Clinical Trial

Official title:
A Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation

Status Completed

Clinical Trial Summary

Purpose of this study is to evaluate the efficacy of at-home administration of a single application of abametapir lotion 0.74% w/w for the treatment of head lice.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02062060
Study type	Interventional
Source	Dr. Reddy's Laboratories Limited
Contact
Status	Completed
Phase	Phase 3
Start date	February 2014
Completion date	August 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02097485` - Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation	Phase 2
Recruiting	`NCT04878276` - Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once
Completed	`NCT01907490` - Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation	Phase 2
Completed	`NCT02060903` - A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation	Phase 3
Recruiting	`NCT06057506` - Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice Infestation	N/A
Completed	`NCT02010333` - A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation	Phase 2